Literature DB >> 35069029

Anorectal Strictures in Complex Perianal CD: How to Approach?

Amy L Lightner1, Miguel Regueiro2.   

Abstract

Anorectal strictures are a notoriously difficult to treat phenotype of perianal Crohn's disease. Quality of life is diminished due to ongoing pain, incontinence, difficulty with stool evacuation, and recurrent medical and surgical treatments. Medical therapy is aimed at treating luminal disease and mucosal ulceration to prevent worsening of fibrosis. Clinical examination and endoscopic intervention can be used for serial dilations of strictures. Unfortunately, despite optimal medical therapy and endoscopic intervention with serial anal dilations, surgery with intestinal diversion or proctocolectomy may be required as part of the treatment algorithm in a significant proportion of patients. Thieme. All rights reserved.

Entities:  

Keywords:  anal canal disease; anal stenosis; proctocolectomy

Year:  2022        PMID: 35069029      PMCID: PMC8763464          DOI: 10.1055/s-0041-1740037

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN: 1530-9681


  60 in total

1.  Role of a defunctioning stoma in the management of large bowel Crohn's disease.

Authors:  C M Edwards; B D George; D P Jewell; B F Warren; N J Mortensen; M G Kettlewell
Journal:  Br J Surg       Date:  2000-08       Impact factor: 6.939

2.  Perianal Crohn disease: predictors of need for permanent diversion.

Authors:  Susan Galandiuk; Jennifer Kimberling; Talib G Al-Mishlab; Arnold J Stromberg
Journal:  Ann Surg       Date:  2005-05       Impact factor: 12.969

3.  Budesonide enema for the treatment of active, distal ulcerative colitis and proctitis: a dose-ranging study. U.S. Budesonide enema study group.

Authors:  S B Hanauer; M Robinson; R Pruitt; A J Lazenby; T Persson; L G Nilsson; K Walton-Bowen; L P Haskell; J G Levine
Journal:  Gastroenterology       Date:  1998-09       Impact factor: 22.682

4.  Cancer of the anus complicating perianal Crohn's disease.

Authors:  K M Devon; C J Brown; M Burnstein; R S McLeod
Journal:  Dis Colon Rectum       Date:  2009-02       Impact factor: 4.585

5.  Intersphincteric proctectomy with end-colostomy for anorectal Crohn's disease results in early and severe proximal colonic recurrence.

Authors:  Anthony de Buck van Overstraeten; Albert M Wolthuis; Séverine Vermeire; Gert Van Assche; Paul Rutgeerts; Freddy Penninckx; André D'Hoore
Journal:  J Crohns Colitis       Date:  2012-08-11       Impact factor: 9.071

6.  Adenocarcinoma associated with perianal fistulas in Crohn's disease.

Authors:  Hitoshi Ogawa; Sho Haneda; Chikashi Shibata; Koh Miura; Munenori Nagao; Shinobu Ohnuma; Atsushi Kohyama; Michiaki Unno
Journal:  Anticancer Res       Date:  2013-02       Impact factor: 2.480

7.  Healing of severe perineal and cutaneous Crohn's disease with hyperbaric oxygen.

Authors:  C E Brady; B J Cooley; J C Davis
Journal:  Gastroenterology       Date:  1989-09       Impact factor: 22.682

8.  Clinical trial: a novel high-dose 1 g mesalamine suppository (Salofalk) once daily is as efficacious as a 500-mg suppository thrice daily in active ulcerative proctitis.

Authors:  Tilo Andus; Andreas Kocjan; Moritz Müser; Andrey Baranovsky; Tatyana L Mikhailova; Tatyana D Zvyagintseva; Andrey E Dorofeyev; Yurii S Lozynskyy; Ingolf Cascorbi; Manfred Stolte; Michael Vieth; Karin Dilger; Ralf Mohrbacher; Roland Greinwald
Journal:  Inflamm Bowel Dis       Date:  2010-11       Impact factor: 5.325

Review 9.  Modern management of perianal fistulas in Crohn's disease: future directions.

Authors:  Paulo Gustavo Kotze; Bo Shen; Amy Lightner; Takayuki Yamamoto; Antonino Spinelli; Subrata Ghosh; Remo Panaccione
Journal:  Gut       Date:  2018-01-13       Impact factor: 23.059

Review 10.  Role of interventional inflammatory bowel disease in the era of biologic therapy: a position statement from the Global Interventional IBD Group.

Authors:  Bo Shen; Gursimran Kochhar; Udayakumar Navaneethan; Xiuli Liu; Francis A Farraye; Yago Gonzalez-Lama; David Bruining; Darrell S Pardi; Martin Lukas; Martin Bortlik; Kaicun Wu; Ajit Sood; David A Schwartz; William J Sandborn
Journal:  Gastrointest Endosc       Date:  2018-10-24       Impact factor: 9.427

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.